154
Views
12
CrossRef citations to date
0
Altmetric
Clinical Trial Report

TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure

, , , , , , & show all
Pages 897-904 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pantelis A Sarafidis, Panagiotis I Georgianos & Anastasios N Lasaridis. (2010) Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds. Expert Opinion on Drug Safety 9:2, pages 243-257.
Read now

Articles from other publishers (11)

Yukihiro Watanabe, Yoshiaki Kubota, Takuya Nishino, Shuhei Tara, Katsuhito Kato, Daisuke Hayashi, Kosuke Mozawa, Junya Matsuda, Yukichi Tokita, Masahiro Yasutake, Kuniya Asai & Yu‐ki Iwasaki. (2023) Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease. ESC Heart Failure 10:3, pages 1706-1716.
Crossref
Kazutaka Nogi, Tomoya Ueda, Takuya Nakamura, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Yukihiro Hashimoto, Hitoshi Nakagawa, Taku Nishida, Ayako Seno, Kenji Onoue, Makoto Watanabe & Yoshihiko Saito. (2023) New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure. Journal of the American Heart Association 12:1.
Crossref
Kazutaka Nogi, Rika Kawakami, Tomoya Ueda, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Yukihiro Hashimoto, Hitoshi Nakagawa, Taku Nishida, Ayako Seno, Kenji Onoue, Tsunenari Soeda, Makoto Watanabe & Yoshihiko Saito. (2021) Prognostic Value of Fractional Excretion of Urea Nitrogen at Discharge in Acute Decompensated Heart Failure. Journal of the American Heart Association 10:16.
Crossref
Jordan E. Morningstar, Annah Nieman, Christina Wang, Tyler Beck, Andrew Harvey & Russell A. Norris. (2021) Mitral Valve Prolapse and Its Motley Crew‐Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition. Journal of the American Heart Association 10:13.
Crossref
Camille Poissonnier, Sarra Ghazal, Peggy Passavin, Maria-Paz Alvarado, Solène Lefort, Emilie Trehiou-Sechi, Vittorio Saponaro, Alix Barbarino, Julia Delle Cave, Charlie-Rose Marchal, Boris Depré, Etienne Vannucci, Renaud Tissier, Patrick Verwaerde & Valérie Chetboul. (2020) Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016–2019). BMC Veterinary Research 16:1.
Crossref
Matthew Webber, Stephen P. Jackson, James C. Moon & Gabriella Captur. (2020) Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials. Cardiology and Therapy 9:2, pages 363-376.
Crossref
V. Chetboul, J.-L. Pouchelon, J. Menard, J. Blanc, L. Desquilbet, A. Petit, S. Rougier, L. Lucats & F. Woehrle. (2017) Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study. Journal of Veterinary Internal Medicine 31:6, pages 1629-1642.
Crossref
Vijaya M Musini, Pouria Rezapour, James M Wright, Ken Bassett & Ciprian D Jauca. (2015) Blood pressure-lowering efficacy of loop diuretics for primary hypertension. Cochrane Database of Systematic Reviews 2015:5.
Crossref
Tomoya Ueda, Rika Kawakami, Yu Sugawara, Sadanori Okada, Taku Nishida, Kenji Onoue, Tsunenari Soeda, Satoshi Okayama, Yukiji Takeda, Makoto Watanabe, Hiroyuki Kawata, Shiro Uemura & Yoshihiko Saito. (2014) Worsening of Renal Function During 1 Year After Hospital Discharge Is a Strong and Independent Predictor of All‐Cause Mortality in Acute Decompensated Heart Failure. Journal of the American Heart Association 3:6.
Crossref
Vijaya M Musini, Pouria Rezapour, James M Wright, Ken Bassett & Ciprian D Jauca. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. (2011) Effects of Prolonged-Release Torasemide Versus Furosemide on Myocardial Fibrosis in Hypertensive Patients with Chronic Heart Failure: A Randomized, Blinded–End Point, Active-Controlled Study. Clinical Therapeutics 33:9, pages 1204-1213.e3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.